Yeast as a tool to uncover the cellular targets of drugs

Christopher M Sturgeon1, Danielle Kemmer, Hilary J Anderson

  • 1Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.

Biotechnology Journal
|August 10, 2006
PubMed

Insights

Discovering drug targets is crucial for therapeutic development. This review explores using the yeast Saccharomyces cerevisiae and various methods, including gene expression analysis and protein chips, to efficiently identify drug targets.

Area of Science:

  • Biochemistry
  • Genetics
  • Pharmacology

Background:

  • Identifying cellular targets of therapeutic agents is essential for effective drug development.
  • Drug target identification presents a significant challenge in pharmaceutical research.

Purpose of the Study:

  • To review the utility of the yeast Saccharomyces cerevisiae as a model organism for drug target discovery.
  • To discuss various methods for identifying drug targets in yeast and their comparative advantages and disadvantages.

Main Methods:

  • Utilizing Saccharomyces cerevisiae's genetic tractability to alter gene expression and assess drug sensitivity.
  • Inferring drug mechanisms of action by analyzing changes in mRNA expression profiles.
  • Employing yeast protein chips to directly identify proteins that bind to therapeutic agents.

Main Results:

  • Yeast offers a powerful platform for drug target identification due to conserved human pathways.
  • Combining genetic manipulation, transcriptomic analysis, and protein-chip technologies can enhance target discovery efficiency.

Conclusions:

  • Saccharomyces cerevisiae provides a versatile system for uncovering drug targets and elucidating mechanisms of action.
  • Integrated approaches leveraging yeast's capabilities offer a promising strategy for accelerating drug development.

Related Concept Videos

Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...
Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...